These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8957107)

  • 1. Immunoregulatory circuits and potential treatment of connective tissue diseases.
    Alcocer-Varela J; Llorente L; Alarcón-Segovia D
    Int Arch Allergy Immunol; 1996 Dec; 111(4):348-54. PubMed ID: 8957107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
    Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
    Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of the PD-1 protein in pathogenesis of autoimmune diseases, with particular consideration of rheumatoid arthritis and systemic lupus erythematosus].
    Siwiec A; Majdan M
    Postepy Hig Med Dosw (Online); 2015 Apr; 69():534-42. PubMed ID: 25983292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum cortisol reduction and abnormal prolactin and CD4+/CD8+ T-cell response as a result of controlled exercise in patients with rheumatoid arthritis and systemic lupus erythematosus despite unaltered muscle energetics.
    Pool AJ; Whipp BJ; Skasick AJ; Alavi A; Bland JM; Axford JS
    Rheumatology (Oxford); 2004 Jan; 43(1):43-8. PubMed ID: 12867581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymulin (FTS-Zn) induced in vitro modulation of T cell subsets markers on lymphocytes from rheumatoid arthritis and systemic lupus erythematosus patients.
    Faure G; Bene MC; Tamisier JN; Gaucher A; Duheille J
    Int J Immunopharmacol; 1984; 6(4):381-8. PubMed ID: 6332789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of blocking IL-6 outside of rheumatoid arthritis: current perspective.
    Murakami M; Nishimoto N
    Curr Opin Rheumatol; 2011 May; 23(3):273-7. PubMed ID: 21427577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased CCR4 expression on circulating CD4(+) T cells in ankylosing spondylitis, rheumatoid arthritis and systemic lupus erythematosus.
    Yang PT; Kasai H; Zhao LJ; Xiao WG; Tanabe F; Ito M
    Clin Exp Immunol; 2004 Nov; 138(2):342-7. PubMed ID: 15498047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human CD4-internal antigen anti-idiotypic monoclonal antibody: induction of a CD4-specific response in humans.
    Perosa F; Scudeletti M; Imro MA; Dammacco F; Indiveri F
    J Immunol; 1996 May; 156(9):3563-9. PubMed ID: 8617987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory T cells and TH1/TH2 cytokines as immunodiagnosis keys in systemic autoimmune diseases.
    Ursaciuc C; Surcel M; Ciotaru D; Dobre M; Pirvu IR; Munteanu AN; Alecu M; Huică R
    Roum Arch Microbiol Immunol; 2010; 69(2):79-84. PubMed ID: 21235134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct transfer of p65 into T lymphocytes from systemic lupus erythematosus patients leads to increased levels of interleukin-2 promoter activity.
    Herndon TM; Juang YT; Solomou EE; Rothwell SW; Gourley MF; Tsokos GC
    Clin Immunol; 2002 May; 103(2):145-53. PubMed ID: 12027419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG subclasses of antibodies to type II collagen in rheumatoid arthritis differ from those in systemic lupus erythematosus and other connective tissue diseases.
    Cook AD; Mackay IR; Cicuttini FM; Rowley MJ
    J Rheumatol; 1997 Nov; 24(11):2090-6. PubMed ID: 9375865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologic Therapies for Autoimmune and Connective Tissue Diseases.
    Wolfe RM; Ang DC
    Immunol Allergy Clin North Am; 2017 May; 37(2):283-299. PubMed ID: 28366477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of anti-CD4 antibodies on the release of IL-6 and TNF-alpha in whole blood samples from patients with systemic lupus erythematosus.
    Brink I; Thiele B; Burmester GR; Trebeljahr G; Emmrich F; Hiepe F
    Lupus; 1999; 8(9):723-30. PubMed ID: 10602444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Senescent profile of angiogenic T cells from systemic lupus erythematosus patients.
    López P; Rodríguez-Carrio J; Martínez-Zapico A; Caminal-Montero L; Suarez A
    J Leukoc Biol; 2016 Mar; 99(3):405-12. PubMed ID: 26232454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crossroads of B cell activation in autoimmunity: rationale of targeting B cells.
    Dörner T
    J Rheumatol Suppl; 2006 May; 77():3-11. PubMed ID: 16652439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus.
    Eisenberg R; Albert D
    Nat Clin Pract Rheumatol; 2006 Jan; 2(1):20-7. PubMed ID: 16932648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell regulatory disturbances in the rheumatic diseases.
    Alpert SD; Koide J; Takada S; Engleman EG
    Rheum Dis Clin North Am; 1987 Dec; 13(3):431-45. PubMed ID: 2893438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-CD20 monoclonal antibody in rheumatoid arthritis and systemic lupus erythematosus.
    Goldblatt F; Isenberg DA
    Handb Exp Pharmacol; 2008; (181):163-81. PubMed ID: 18071946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of activated cytokine pathways in the blood of systemic lupus erythematosus, myositis, rheumatoid arthritis, and scleroderma patients.
    Higgs BW; Zhu W; Richman L; Fiorentino DF; Greenberg SA; Jallal B; Yao Y
    Int J Rheum Dis; 2012 Feb; 15(1):25-35. PubMed ID: 22324944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic, prognostic and therapeutic aspects of systemic lupus erythematosus and rheumatoid arthritis.
    Weyand C
    Klin Wochenschr; 1990; 68 Suppl 21():55-63. PubMed ID: 2198390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.